Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14

Trial Status

Completed4
Recruiting3
Terminated1
Other2

Role Distribution

Principal Investigator10
PI Rate100%

Activity Timeline

Clinical Trials (10)

NCT06238531Phase 1Withdrawn
A Clinical Trial to Evaluate Safety of Gusacitinib in Patients With Systemic Lupus Erythematosus (SLE) or Lupus
Systemic Lupus Erythematosus
PrincipalinvestigatorStart date: 2025-01-22
NCT05567198Recruiting
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
Primary Ovarian Insufficiency (Poi)Systemic Lupus Erythematosus (Sle)
PrincipalinvestigatorStart date: 2023-03-03
NCT01716312Phase 1Completed
Omalizumab for Lupus
Sjogren's SyndromeSystemic Lupus Erthematosus
PrincipalinvestigatorStart date: 2014-01-08
NCT00031174Terminated
Blood Component Collection From Patients With Rheumatic or Kidney Disease and Healthy Volunteers
Healthy VolunteersRheumatic Diseases
PrincipalinvestigatorStart date: 2002-02-13
NCT00024479Recruiting
Studies of the Natural History of Rheumatic Diseases
ArthritisRheumatic Diseases
PrincipalinvestigatorStart date: 2001-10-03
NCT00001372Recruiting
Study of Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
PrincipalinvestigatorStart date: 1994-02-10
NCT00046774Phase 1Completed
Monoclonal Antibody Treatment for Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Principalinvestigator
NCT00544102Completed
Insulin Resistance and Atherosclerosis in Women With Lupus
AtherosclerosisInsulin ResistanceSystemic Lupus Erythematosus
Principalinvestigator
NCT02535689Phase 1Completed
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Principalinvestigator
NCT07829497Not Yet Recruiting
Pain Phenotyping of Rheumatic Diseases - An Observational Study
Ankylosing SpondylarthritisArthritisLupus Erythematosus, Systemic+5 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (10)

Showing 10 of 10 trials

NCT06238531Phase 1PrincipalInvestigator

A Clinical Trial to Evaluate Safety of Gusacitinib in Patients With Systemic Lupus Erythematosus (SLE) or Lupus

Systemic Lupus Erythematosus
Withdrawn
NCT05567198PrincipalInvestigator

Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

Primary Ovarian Insufficiency (Poi)Systemic Lupus Erythematosus (Sle)
Recruiting
NCT01716312Phase 1PrincipalInvestigator

Omalizumab for Lupus

Sjogren's SyndromeSystemic Lupus Erthematosus
Completed
NCT00031174PrincipalInvestigator

Blood Component Collection From Patients With Rheumatic or Kidney Disease and Healthy Volunteers

Healthy VolunteersRheumatic Diseases
Terminated
NCT00024479PrincipalInvestigator

Studies of the Natural History of Rheumatic Diseases

ArthritisRheumatic Diseases
Recruiting
NCT00001372PrincipalInvestigator

Study of Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
Recruiting
NCT00046774Phase 1PrincipalInvestigator

Monoclonal Antibody Treatment for Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
Completed
NCT00544102PrincipalInvestigator

Insulin Resistance and Atherosclerosis in Women With Lupus

AtherosclerosisInsulin ResistanceSystemic Lupus Erythematosus
Completed
NCT02535689Phase 1PrincipalInvestigator

Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
Completed
NCT07829497PrincipalInvestigator

Pain Phenotyping of Rheumatic Diseases - An Observational Study

Ankylosing SpondylarthritisArthritisLupus Erythematosus, Systemic+5 more
Not Yet Recruiting

All 10 trials loaded